Company Analysis

Pomdoctor Limited (POM)

Nasdaq: POM · Retail-Miscellaneous Retail · filing with the SEC since 2021
Grade4.6
◀ Past 4.7● Present 4.0▶ Future 5.4
3 est.

Income statement, as filed

In Chinese yuan (CNY), as filed; per-share figures in Chinese yuan; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023
Report filedMay 14, 2026··
Revenue399,914,964342,557,920304,852,971
Cost of revenue347,632,853294,863,867266,131,202
Gross profit52,282,11147,694,05338,721,769
Research and development12,864,6563,002,0403,370,945
Sales and marketing96,214,40656,366,43343,678,681
General and administrative59,729,35211,878,33512,314,018
Total operating expenses170,916,93173,485,33360,970,671
Operating income-118,634,820-25,791,280-22,248,902
Interest expense3,940,3623,632,4253,002,241
Total non-operating income (expense)-12,296,726-11,574,154-14,700,519
Income before income taxes-130,931,546-37,365,434-36,949,421
Income tax expense375··
Income from continuing operations-130,931,921-37,365,434-36,949,421
Net income including non-controlling interests-130,931,921-37,365,434-36,949,421
Net income to non-controlling interests-1,52025,8781,057
Net income to common shareholders-212,579,117-143,360,926-145,390,832
Earnings per share, basic-21.96-22.72-23.04
Earnings per share, diluted-21.96-22.72-23.04
Weighted average shares, basic9,680,6226,310,1986,310,198
Weighted average shares, diluted9,680,6226,310,1986,310,198
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton POM · research, not advice